BioSpace News Archive

BioAge Plans Phase 2 Clinical trial in Hospitalized COVID-19 Patients Clinical development plan supported by potent inhibition of PGD2 DP1 Receptor by BGE-175 , activating immune-modulating mechanisms that result in 100% survival in aged preclinical models of coronavirus BioAge’s proprietary human aging data links activation of PGD2 DP1 signaling to increased risk of mortality and susceptibility to infections RICHMOND, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- BioAge Labs, Inc., a biot

Study builds on extensive research showing that granulocyte-macrophage colony stimulating factor (GM-CSF) is needed for effective immune function in the lungs iLeukPulm Phase 2 Clinical TrIal Supported by $35 Million Contract from U.S. Department of Defense [25-August-2020] LEXINGTON, Mass. , Aug. 25, 2020 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a

Bioscience firm applies AI and data science to identify existing drugs Atozet and Cablivi as potentially effective therapies for blood clots and inflammation caused by COVID-19

IsoPlexis partners with Medquest to expand its single-cell proteomic analysis platform, the IsoLight system and IsoCode & CodePlex Chips, throughout the pharmaceutical and life science markets in Malaysia and Singapore [25-August-2020] BRANFORD, Conn. , Aug. 25, 2020 /PRNewswire/ -- IsoPlexis, the leader in single-cell proteomics products, today announced an exclu

NowRx , a tech-enabled on-demand pharmacy providing same-day and same-hour prescription delivery, today announced that it will be presenting at the LD 500 Investor Conference on September 3, 2020 at 8:40 a.m. ET / 5:40 a.m. PT. Cary Breese, CEO and Co-Founder of NowRx, will be presenting to a live virtual audience. Retail pharmacy is a $400 billion industry that relies on expensive real estate to drive foot traffic and depends on outdate

Proceeds to support Lung Association mission to save lives and prevent lung disease through education, advocacy and research

Medallia, Inc. (NYSE: MDLA), the global leader in experience management, today announced that Medallia Zingle has achieved HIPAA compliance for the healthcare and life sciences industries.

ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, today announced that 5,000 metacarpal fractures have been successfully treated with the INnate Intramedullary Threaded Nail.

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor , President and Chief Executive Officer will present at the LD 500 Virtual Conference on Wednesday, September 2, 2020 . The prese

Illumina (NASDAQ: ILMN) announced today that Kathryne Reeves will join the company as Chief Marketing Officer on September 28, 2020. Reeves brings more than 25 years of marketing and general management experience in roles across the healthcare, technology, and consumer products industries. Reeves will report to Chief Executive Officer, Francis deSouza. This press release features multimedia. View the full release here: htt